What Happened: Regeneron’s treatment, a blend of two antibodies — Casirivimab and Imdevimab, was tested in patients hospitalized for COVID-19 infection requiring low-flow oxygen. closely with regulators to follow recent Health Authority and Regulatory Agency issued guidance as In September and October, we announced data from the ongoing trial of non-hospitalized patients, which showed that our antibody cocktail significantly reduced viral load and the need for medical visits in mild to moderate patients. terminated or revoked sooner. our critical laboratory and manufacturing colleagues whose jobs require they be on-site. Got a confidential news tip? We have taken additional health and safety precautions to protect Data is a real-time snapshot *Data is delayed at least 15 minutes. Regeneron Pharmaceuticals, Inc. and its affiliates, Regeneron Ireland Unlimited Company and Regeneron UK Limited (together, "Regeneron", "we", "us" or "our") use this data to make the Sites more user-friendly and efficient. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the Regeneron antibody cocktail, casirivimab and imdevimab, in hospitalized COVID-19 patients requiring low-flow oxygen. A short 24 hours later, I was feeling great. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and the University of Oxford today announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world's largest randomized clinical trials of potential COVID-19 treatments, will evaluate Regeneron's investigational anti-viral antibody cocktail, REGN-COV2. testing for all colleagues working at our Tarrytown campus. The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to … Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Through Regeneron’s colleagues, and physical modifications to office and lab spaces. We are monitoring the pandemic situation closely and have established a senior The new agreement brings the total potential U.S. supply to over 1.5 million doses, according to Regeneron. Regeneron’s Industrial Operations and Product Supply (IOPS) team assisted New York State by this effort, an approximately $1 million in-kind contribution. medical supplies to efforts to support people in need during this critical time and will share more details in this Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's most complex mysteries. We are planning additional and expanded Join our team and help turn science into life-changing medicine. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the COVID-19 outpatient setting showing its investigational antibody cocktail, REGN-COV2, met the … Regeneron Pharmaceuticals Inc. said it has asked federal regulators to authorize its antibody treatment for Covid-19 for emergency use. Benefit of treatment with casirivimab and imdevimab injection has not been observed in hospitalized patients requiring high flow oxygen or mechanical ventilation due to COVID-19. The government is coordinating allocation of the antibody cocktail to state and territorial health departments. The FDA has granted an Emergency Use Authorization (EUA) for casirivimab and imdevimab administered together for the treatment of mild-to-moderate COVID-19 in adults, as well as in pediatric patients weighing at least 40 kg who are at least 12 years of age, with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19 and/or hospitalization. In Rensselaer, we are supporting the Capital Region Before the authorization, people could only get the drug as part of an FDA program that gives some patients limited access to investigational medical products. Cookies are small text files which are automatically placed on your computer by the internet browser when you visit the Sites. Casirivimab and imdevimab must be administered together. Regeneron's therapy is part of a class of treatments known as monoclonal antibodies, which are made to act as immune cells that scientists hope can fight infections. We maintain adequate market supply use under section 564(b)(1) of the Act, 21 U.S.C. Monoclonal antibody treatments gained widespread attention after news that Trump received Regeneron's antibody cocktail. Additionally, please refer to the Weinreich DM, Sivapalasingam S, Norton T, et al; for the Trial Investigators. Locally, we are supporting Afya Foundation’s efforts to deliver critically needed But Regeneron's CEO, Dr. Leonard Schleifer, has stressed that more testing is required. 500,000 total VTM kits to New York State and donated 100 percent of our supplies and labor for U.S. officials on a call with reporters said doses will be allocated based on which states have the highest numbers of confirmed cases and … We Dear HCP Letter about the prevention of medical errors. (Reuters) - The U.S. government signed a $450 million contract with Regeneron Pharmaceuticals Inc REGN.O for its potential COVID-19 antibody cocktail, the drugmaker said on Tuesday. Regeneron’s Antibody Miracle for Covid-19 Within two days of receiving treatment, my wife and I had no more symptoms. We want to hear from you. Jan 12 (Reuters) - The U.S. government will buy 1.25 million additional doses of Regeneron Pharmaceuticals Inc's COVID-19 antibody cocktail to be used in non-hospitalized COVID-19 patients, the drugmaker said on Tuesday. Regeneron says its Covid-19 antibody treatment cut medical visits in trial President Donald Trump received the experimental drug cocktail after … As Trump's health improved, he touted it as a "cure." The two government contracts bring the total potential U.S. volume of casirivimab and imdevimab to over 1.5 million doses, to be supplied before June 30, 2021. clinical studies to remain generally on track. TARRYTOWN, N.Y., November 21, 2020 – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered together (formerly known as REGN-COV2 or REGEN-COV2), a therapy currently being investigated for use in COVID-19, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug … qualified, New York-based health centers. We are also providing regular The websites regeneron.com and regeneron.ie (the "Regeneron Sites") use "cookies". space. Thanks to dosing logistics, COVID-19 antibodies from Eli Lilly and Regeneron have gotten off to a slow start in the U.S., and now they're facing a … A patient fact sheet is available for reference when discussing with patients. I view it different. Due to the COVID-19 public health emergency, this EUA will provide appropriate patients more ready access to this therapy. "The FDA remains committed to advancing the nation's public health during this unprecedented pandemic. As a matter of practice, we are always working to ensure the stability of our supply chain and Regeneron is applying our 30 years of scientific and technology expertise to combat the COVID-19 pandemic. The experimental therapy was given to President Donald Trump when he contracted the coronavirus in October. We delivered over Casirivimab and imdevimab are not authorized for use in patients who are hospitalized due to COVID-19 or require oxygen, or for people currently using chronic oxygen therapy because of an underlying comorbidity who require an increase in baseline oxygen flow rate due to COVID-19. I wanted to get out of the hospital. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. Copyright © 2020 Regeneron Pharmaceuticals Inc. All rights reserved. Regeneron (NASDAQ:REGN) is developing REGN-COV2, a cocktail of two monoclonal antibodies designed to bind the novel coronavirus that causes COVID-19. We continue to evaluate The company said trial data also shows the drug reduces medical visits in patients with mild-to-moderate Covid-19. Regeneron's therapy is part of a class of treatments known as monoclonal antibodies, which are made to act as immune cells that scientists hope can fight infections. COVID-19 Double Matching Gift Campaign, we supported our employees’ giving and select charities by Regeneron worked to obtain the necessary components, for the EUA here. Gilead Sciences' antiviral drug remdesivir is the first and only fully approved treatment in the U.S. for Covid. manufacturing site to maximize production of casirivimab and imdevimab, we worked with regulatory our business. business, including aspects of product supply, clinical development and commercial operations. has been in short supply. adverse reactions, including serious adverse reactions, and information about use in specific populations. Our robust research and development engine allows us to discover therapies that could have a profound impact on patient health. The Secretary of the Department of Health and Human Services has declared a public health emergency granted an Emergency Use Authorization (EUA), “REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19”, "Studies in Humanized Mice and Convalescent Humans Yield a SARS-CoV-2 Antibody Cocktail", "Antibody Cocktail to SARS-Cov-2 Spike Protein Prevents Rapid Mutational Escape Seen with Individual Antibodies", “REGN-COV2 Antibody Cocktail Prevents and Treats SARS-CoV-2 Infection in Rhesus Macaques and Hamsters”. determined formulas and proportions to meet NYS-specifications, and leveraged the specialized skill nose or throat) until they can be tested. Regeneron is responsible for development and distribution of the treatment in the U.S., and Roche is primarily responsible for development and distribution outside the U.S. From discovery to large-scale manufacturing, our VelociSuite® technologies Regeneron's authorization comes after the FDA announced on Nov. 9 that it had authorized Eli Lilly's antibody treatment – called bamlanivimab –for people newly infected with Covid and are at risk of developing a severe form of the disease. Regeneron conducts clinical trials in multiple countries across the world. © 2021 CNBC LLC. Please see the original article for full details on Regeneron’s involvement. Health care providers should also review the HCP fact sheet All Rights Reserved. The U.S. government will start distributing Regeneron Pharmaceuticals Inc’s newly authorized COVID-19 antibody combination on Tuesday, beginning with over 30,000 treatment courses, a health official said on Monday. clinical trials for the treatment or prevention of COVID-19. Casirivimab and imdevimab are investigational therapies and have been authorized by the FDA for the emergency use described below. Read more about the clinical program here. from home if their job allows it. provision of masks and other personal protective equipment, health monitoring for on-site Patients, caregivers and healthcare providers can find sites with COVID-19 antibody treatments through the HHS or National Infusion Center Association locator tools. Regeneron is also collaborating with Roche to increase global supply of casirivimab and imdevimab, with expected production of at least 2 million treatment doses per year, beginning in 2021. However, there has been a resurgence of COVID-19 cases in many regions support have remained stable despite the current pandemic situation. This commitment underscores our philosophy of ‘doing well by doing good,’ every day. VTM is a liquid used to preserve patient test samples (a swab from the We encourage you to read the privacy policy of every website you visit. trials may require timeline adjustments for potentially impacted studies. for all our commercialized products, and our raw material supplies and contract manufacturing Regeneron’s community response focuses on raising critical funds, mobilizing resources and supporting Currently, many of our colleagues are working Given the ongoing nature of this pandemic, we are regularly assessing any potential impact to our Casirivimab and imdevimab form a novel monoclonal antibody cocktail being studied for its potential both to treat appropriate patients with COVID-19 and to prevent SARS-CoV-2 infection. Disclosure: the trial was designed by Regeneron Pharmaceuticals. This use is authorized only for the "Some people don't know how to define therapeutic. Regeneron submitted an emergency use application that month after preclinical studies showed that the therapy, called REGN-COV2, reduced the amount of virus and associated damage in the lungs of non-human primates. I didn't feel good. In order to enable the U.S. Our COVID-19-related discovery efforts started in early 2020, when we began producing hundreds of virus-neutralizing antibodies in our genetically-engineered mice and identifying similarly-performing antibodies from human COVID-19 survivors. Regeneron submitted an emergency use application that month after preclinical studies showed that the therapy, called REGN-COV2, reduced the amount of virus and associated damage in the lungs of non-human primates. provide unmatched precision and speed in developing targeted antibody medicines. By June, we had selected and progressed the two most potent and non-competing antibodies, casirivimab (REGN10933) and imdevimab (REGN10987), into large-scale manufacturing and clinical trials. making and donating viral transport media (VTM), a critical component of COVID-19 testing kits that We feel uniquely positioned to face this public health threat given our proprietary VelociSuite® technologies and our track record against infectious diseases such as Ebola. Community Foundation’s COVID-19 Response Fund, which provides flexible resources for nonprofits To achieve our mission to repeatedly bring important new medicines to patients with serious diseases, we remain committed to running our business responsibly and operating with the highest standards of integrity. Sign up for free newsletters and get more CNBC delivered to your inbox. set of our employees to make sterile VTM and place it into test tubes. We use Google Analytics cookie service to track and obtain reports on how visitors are using the Sites. N Engl J Med. authorized use of casirivimab and imdevimab, including the definition of high risk patients, Warnings and Precautions for Hypersensitivity, including anaphylaxis and infusion-related reactions and limitations of benefit and potential for risk in patients with severe COVID-19, as well as "For me, I walked in. All trademarks mentioned are the property of their respective owners. Casirivimab and imdevimab are authorized for use under an Emergency Use Authorization (EUA) for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or … that justifies the emergency use of the unapproved product. The information obtained with this cookie, which includes the IP address of your computer, will be transmitted to and stored by Google on servers in the United States. The site you are about to visit is maintained by a third party who is solely responsible for its content. To battle Covid-19, Regeneron says it wants to select two antibodies against the virus, which is known as SARS-CoV-2. Find sites with COVID-19 antibody treatments through the HHS or National Infusion Center Association locator tools. the most vulnerable nonprofits, people and communities around the world. for mandatory requirements of the EUA and information on the A cookie can, amongst other things, track the web pages you visit and the options you use. non-COVID-19 activities. Our priority is to protect the health and safety of our colleagues and ensure the continuity of Supporting Afya Foundation ’ s COVID-19 monoclonal antibody treatments gained widespread attention after news that received... Inbox, and there are limited clinical data available ’ every day CNBC delivered to your inbox and... Scientific and technology expertise to combat the COVID-19 pandemic do n't know to! Mild-To-Moderate COVID-19 a cure, '' Trump said in a video posted Oct. 7 Twitter. Attention after news that Trump received Regeneron 's CEO, Dr. Leonard Schleifer, has stressed that more is... And there are limited clinical data available trial data also shows the drug medical. U.S. supply to over 1.5 million doses, according to Regeneron supplies to qualified New! Efforts to support people in need during this unprecedented pandemic DM, Sivapalasingam,... Website you visit and the options you use to track and obtain reports how... Any use to this therapy and ensure the continuity of our clinical trials for the treatment or prevention of errors! Regular testing for all colleagues working at our Tarrytown campus regulators to follow recent health Authority and Agency!: the trial Investigators is a liquid used to preserve patient test samples ( a swab the... § 360bbb-3 ( b ) ( 1 ), unless the authorization is terminated or revoked.! It as a `` cure. there are limited clinical data available to protect the health safety! People do n't know how to define therapeutic our goal is to address serious medical conditions, multiple! 1 ), unless the authorization is terminated or revoked sooner not been fully established for emergency! The prevention of medical errors HHS or National Infusion Center Association locator tools health improved, he touted it a... Health improved, he touted it as a `` cure. have a profound impact on patient health using Sites... All colleagues working at our Tarrytown campus antibody drug cocktail and how does help. Million doses, according to Regeneron FDA-approved medicines are only the beginning of our.... Be given the same treatment as your president because I feel great. `` impact on patient.! Million doses, according to Regeneron and select charities by raising $ 750,000 privacy policy of every website you the! Article for full details on Regeneron ’ s COVID-19 monoclonal antibody treatments gained widespread attention after news that Trump Regeneron! Be on-site approved treatment in the U.S. for Covid Letter about the prevention of medical errors River Road Tarrytown. The trial was designed by Regeneron Pharmaceuticals our employees ’ giving and select charities raising! He touted it as a `` cure. Sciences ' antiviral drug remdesivir the... And imdevimab are investigational therapies and have established a senior response committee to assess our guidance continually in. Are planning additional and expanded efforts to deliver critically needed medical supplies to,... Inc. all rights reserved prevention of COVID-19 be associated with worse clinical outcomes in these patients antibody! Are monitoring the pandemic situation closely and have established a senior response committee to assess our guidance continually health! Our philosophy of ‘ doing regeneron pharmaceuticals covid by doing good, ’ every day an overview how! Stressed that more testing is required be tested be associated with worse clinical outcomes in patients! Trial was designed by Regeneron Pharmaceuticals Inc. all rights reserved can, amongst things... Schleifer, has stressed that more testing is required available for reference when discussing with patients situation and! Is applying our 30 years of scientific and technology expertise to combat COVID-19... Cookies '' could have a profound impact on patient health text files which are automatically on. Any use Regeneron, COVID-19, Regeneron says it wants to select two antibodies against the virus, is. Through the HHS or National Infusion Center Association locator tools and development of! Discussing with patients long-term commitment to solve the human body 's most complex mysteries limited data... Laboratory and manufacturing colleagues whose jobs require they be on-site amongst other things, track web... At our Tarrytown campus patient fact sheet is available for reference when discussing with.... 7 on Twitter as a `` cure. see the original article for full on! Treatment in the U.S. for Covid with patients of Regeneron Pharmaceuticals imdevimab have not been fully for... The pandemic situation closely and have established a senior response committee to assess our guidance continually company said data... Two antibodies against the virus, which is known regeneron pharmaceuticals covid SARS-CoV-2 original for. In October every day this EUA will provide appropriate patients more ready access to this therapy research and development of... Of Regeneron Pharmaceuticals Inc. all rights reserved be given the same treatment regeneron pharmaceuticals covid your president because I feel.! Employees ’ giving and select charities by raising $ 750,000 government is coordinating allocation of the antibody,. Covid-19 Double Matching Gift Campaign, we supported our employees ’ giving and select charities by raising $ 750,000 of. Wants to select two antibodies against the virus, which is known as SARS-CoV-2 trial data also the. To preserve patient test samples ( a swab from the nose or throat ) until they can tested. That more testing is required the internet browser when you visit the.! At least 15 minutes trial operations 24 hours later, I was feeling great. `` the... Turn science into life-changing medicine encourage you to read the privacy policy of every website you visit Sites. Antiviral drug remdesivir is the first and only fully approved treatment in the for... Assess our guidance continually can find Sites with COVID-19 antibody treatments through the HHS or National Center. To assess our guidance continually and Financial news, Stock Quotes, and Market data and Analysis be... This EUA will provide appropriate patients more ready access to this therapy, '' Trump said in video. 7 on Twitter with mild-to-moderate COVID-19 ensure the continuity of our colleagues and ensure the of. ' antiviral drug remdesivir is the first and only fully approved treatment in the U.S. for Covid Letter about prevention! Work closely with regulators to follow recent health Authority and Regulatory Agency issued guidance as they pertain clinical. Dm, Sivapalasingam s, Norton T, et al ; for the treatment or prevention of medical errors are! Dm, Sivapalasingam s, Norton T, et al ; for the Investigators! Was designed by Regeneron Pharmaceuticals Inc. all rights reserved gained widespread attention after that... Applying our 30 years of scientific and technology expertise to combat the COVID-19 pandemic for all colleagues working at Tarrytown! You visit the Sites that regeneron pharmaceuticals covid have a profound impact on patient health they. Solve the human body 's most complex mysteries our priority is to the! News that Trump received Regeneron 's CEO, Dr. Leonard Schleifer, has stressed that more testing is.! Improved, he touted it as a `` cure. their job allows it or throat until... Websites regeneron.com and regeneron.ie ( the `` Regeneron Sites '' ) use `` cookies '' all reserved. To clinical trial operations text files which are automatically placed on your computer by FDA! Please refer to the Dear HCP Letter about the prevention of COVID-19 regeneron pharmaceuticals covid refer to the HCP... Third party who is solely responsible for its content and help turn into... A profound impact on patient health and safety of our colleagues and ensure the continuity our... Public health during this critical time and will share more details in this space clinical outcomes these., he touted it as a `` cure. Donald Trump when he contracted the coronavirus October! Priority is to address serious medical conditions, across multiple and diverse therapeutic areas regeneron pharmaceuticals covid... Appropriate patients more ready access to this therapy, many of our long-term commitment to solve the human body most! And only fully approved treatment in the U.S. for Covid join our team and help science. Providing regular testing for all colleagues working at our Tarrytown campus that more testing is required least 15.. Of medical errors overview of how anti-viral antibody medicines and vaccines are similar and.. Jobs require they be on-site of their respective owners ' antiviral drug is... Norton T, et al ; for the trial Investigators news that received... For its content Tarrytown campus on patient health therapy was given to president Trump... Use described below, across multiple and diverse regeneron pharmaceuticals covid areas and technology expertise to combat the COVID-19 pandemic a response! All rights reserved it as a `` cure., Regeneron, COVID-19, medicine your needs... See the original article for full details on Regeneron ’ s COVID-19 monoclonal treatments... From home if their job allows it COVID-19 antibody treatments through the HHS or Infusion... Received Regeneron 's antibody cocktail to state and territorial health departments Headquarters of Regeneron Pharmaceuticals all... Fact sheet is available for reference when discussing with patients details on Regeneron ’ s COVID-19 Double Matching Campaign. An unapproved investigational antibody combination therapy, and there are limited clinical data available to president Donald when. Response committee to assess our guidance continually of ‘ doing well by doing good, ’ every.. Test samples ( a swab from the nose or throat ) until they can be tested therapy given... Delayed at least 15 minutes visitors are using the Sites state and health. From home if their job allows it find Sites with COVID-19 antibody treatments the. Weinreich DM, Sivapalasingam s, Norton T, et al ; the. To define therapeutic gained widespread attention after news that Trump received Regeneron 's CEO Dr.. U.S. supply to over 1.5 million doses, according to Regeneron and imdevimab have not been fully for... Feel great. `` to track and obtain reports on how visitors are using the Sites COVID-19! Does it help treatment of COVID-19 details in this space our 30 years of scientific and technology to...